Literature DB >> 8608006

Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

N C Inestrosa1, A Alvarez, C A Pérez, R D Moreno, M Vicente, C Linker, O I Casanueva, C Soto, J Garrido.   

Abstract

Acetylcholinesterase (AChE), an important component of cholinergic synapses, colocalizes with amyloid-beta peptide (A beta) deposits of Alzheimer's brain. We report here that bovine brain AChE, as well as the human and mouse recombinant enzyme, accelerates amyloid formation from wild-type A beta and a mutant A beta peptide, which alone produces few amyloid-like fibrils. The action of AChE was independent of the subunit array of the enzyme, was not affected by edrophonium, an active site inhibitor, but it was affected by propidium, a peripheral anionic binding site ligand. Butyrylcholinesterase, an enzyme that lacks the peripheral site, did not affect amyloid formation. Furthermore, AChE is a potent amyloid-promoting factor when compared with other A beta-associated proteins. Thus, in addition to its role in cholinergic synapses, AChE may function by accelerating A beta formation and could play a role during amyloid deposition in Alzheimer's brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608006     DOI: 10.1016/s0896-6273(00)80108-7

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  176 in total

1.  A modular treatment of molecular traffic through the active site of cholinesterase.

Authors:  S A Botti; C E Felder; S Lifson; J L Sussman; I Silman
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site.

Authors:  Yves Bourne; Palmer Taylor; Zoran Radić; Pascale Marchot
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

Review 3.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

4.  Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.

Authors:  Cédric Lecoutey; Damien Hedou; Thomas Freret; Patrizia Giannoni; Florence Gaven; Marc Since; Valentine Bouet; Céline Ballandonne; Sophie Corvaisier; Aurélie Malzert Fréon; Serge Mignani; Thierry Cresteil; Michel Boulouard; Sylvie Claeysen; Christophe Rochais; Patrick Dallemagne
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

5.  Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors.

Authors:  Tarek Mohamed; Xiaobei Zhao; Lila K Habib; Jerry Yang; Praveen P N Rao
Journal:  Bioorg Med Chem       Date:  2011-03-01       Impact factor: 3.641

6.  Neuroprotection in Alzheimer's disease - new strategies for treatment.

Authors:  A Nordberg
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

7.  Back-scattering interferometry: an ultrasensitive method for the unperturbed detection of acetylcholinesterase-inhibitor interactions.

Authors:  Gabrielle L Haddad; Sherri C Young; Ned D Heindel; Darryl J Bornhop; Robert A Flowers
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-04       Impact factor: 15.336

8.  Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons.

Authors:  Haiheng Dong; Yun-Yan Xiang; Noa Farchi; William Ju; Yaojiong Wu; Liwen Chen; Yutian Wang; Binyamin Hochner; Burton Yang; Hermona Soreq; Wei-Yang Lu
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

Review 9.  Acetylcholinesterase in Hirschsprung's disease.

Authors:  S W Moore; G Johnson
Journal:  Pediatr Surg Int       Date:  2005-03-10       Impact factor: 1.827

10.  sym-Triazines for directed multitarget modulation of cholinesterases and amyloid-β in Alzheimer's disease.

Authors:  Anthony J Veloso; Devjani Dhar; Ari M Chow; Biao Zhang; Derek W F Tang; Hashwin V S Ganesh; Svetlana Mikhaylichenko; Ian R Brown; Kagan Kerman
Journal:  ACS Chem Neurosci       Date:  2012-11-20       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.